Analyst Price Targets — ADCT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| December 3, 2025 6:43 pm | Gregory Renza | RBC Capital | $5.00 | $3.96 | StreetInsider | RBC Capital on ADC Therapeutics (ADCT): 'We think the downside is unwarranted and would be buyers on weakness' |
| November 12, 2025 11:47 am | Michael Schmidt | Guggenheim | $10.00 | $3.97 | StreetInsider | Guggenheim Reiterates Buy Rating on ADC Therapeutics (ADCT) |
| May 7, 2024 7:10 am | Robert Burns | H.C. Wainwright | $8.00 | $4.45 | StreetInsider | ADC Therapeutics (ADCT) PT Lowered to $8 at H.C. Wainwright |
| March 13, 2024 4:02 pm | Kelly Shi | Jefferies | $13.00 | $3.90 | StreetInsider | ADC Therapeutics (ADCT) PT Lowered to $13 at Jefferies |
| November 14, 2022 7:55 am | — | Morgan Stanley | $7.00 | $4.10 | Benzinga | Morgan Stanley Maintains Equal-Weight on ADC Therapeutics, Lowers Price Target to $7 |
| September 9, 2022 5:19 am | Matthew Harrison | Morgan Stanley | $11.00 | $6.52 | TheFly | ADC Therapeutics downgraded to Equal Weight from Overweight at Morgan Stanley |
| August 22, 2022 6:21 am | — | H.C. Wainwright | $20.00 | $8.42 | Benzinga | HC Wainwright & Co. Maintains Buy on ADC Therapeutics, Lowers Price Target to $20 |
Latest News for ADCT
Here is how ADC Therapeutics SA (ADCT) and Biogen Inc. (BIIB) have performed compared to their sector so far this year.
LAUSANNE, Switzerland, April 1, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that the Company has made a grant of options to purchase an aggregate of 17,000 of the Company's common shares to a new employee on April 1, 2026 ("Grant"). The Grant was offered as material inducement to the employee's…
ADC Therapeutics SA (ADCT) Discusses ZYNLONTA Strategy, Clinical Progress, and Sales Growth Outlook Transcript
Here is how ADC Therapeutics SA (ADCT) and ALX Oncology Holdings Inc. (ALXO) have performed compared to their sector so far this year.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ADCT.
U.S. House Trading
No House trades found for ADCT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.